Identification of Optimal Urinary Biomarkers of Synthetic Cannabinoids BZO-HEXOXIZID, BZO-POXIZID, 5F-BZO-POXIZID, and BZO-CHMOXIZID for Illicit Abuse Monitoring.

Keane Zhi Hao LeeZiteng Wang Ching Yee Fong Evelyn Mei Ling Goh Hooi Moy Yan Eric Chun Yong Chan

Published in: Clinical chemistry (2022)

Drug enforcement agencies worldwide may apply these biomarkers in routine monitoring procedures to identify abusers and counter the escalation of OXIZID abuse.

Keyphrases

intimate partner violence
clinical practice
open label
clinical trial
adverse drug